News — The October issue of highlights new clinical science and reviews on insurance barriers to care in inflammatory bowel disease and colorectal cancer (CRC) screening, a follow-up strategy for small hepatocellular carcinoma, and the role of bowel prep quality in colonoscopy findings and CRC deaths. This month we also published articles on opioids and the GI tract, eosinophilic esophagitis, endoscopy, pediatrics, chronic pancreatitis, and more.
Several articles are highlighted below and access to any articles from this issue, or past issues, is available upon request. The College is also able to connect members of the press with study authors or outside experts who can comment on the articles.
Chen, et al.
In this analysis, the authors aimed to determine an ideal follow-up strategy and schedule for small hepatocellular carcinoma after radiofrequency ablation and evaluate its cost effectiveness. They compared 25 surveillance strategies involving different surveillance techniques, based on a 10-year period. Based on their findings, they recommend CT, with scans scheduled every three months for the first two years, every six months thereafter, and transition to biannual combination of ultrasound screening and α-fetoprotein testing after five years.
Zessner-Spitzenberg, et al.
Study authors assessed the influence of bowel preparation on the detection of different polyp types, based on the Aronchick Scale scores in a large, population-based screening program database in Austria (excellent, good, fair, poor, and inadequate). They found that “fair” bowel preparation was associated with a lower adenoma detection probability and increased risk of post-colonoscopy CRC death.
Constant, et al.
This survey within the IBD Partners longitudinal cohort, an online patient-powered research network, was conducted to evaluate the frequency and patient-reported impacts of medication utilization barriers on insurance satisfaction and clinical outcomes. Barriers included medication denials, prior authorizations, and forced medication switches. Lower insurance satisfaction was associated with insurance barriers generally. Notably, denial of a new medication was associated with a nearly nine-fold increased risk of IBD-related surgery and a two-fold risk of requiring a new steroid prescription.
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of over 19,000 individuals from 86 countries. The College's vision is to be the preeminent organization supporting health care professionals who provide compassionate, equitable, high-quality, state-of-the-art, and personalized care to promote digestive health. The mission of the College is to provide tools, services, and accelerate advances in patient care, education, research, advocacy, practice management, professional development and clinician wellness, enabling our members to improve patients’ digestive health and to build personally fulfilling careers that foster well-being, meaning and purpose. Follow ACG on X @AmCollegeGastro and learn more at .
RSS